These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16051668)

  • 1. Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor alpha.
    Leong H; Sloan JR; Nash PD; Greene GL
    Mol Endocrinol; 2005 Dec; 19(12):2930-42. PubMed ID: 16051668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulator recognition factor 1, an AT-rich interaction domain family member, is a novel corepressor for estrogen receptor alpha.
    Georgescu SP; Li JH; Lu Q; Karas RH; Brown M; Mendelsohn ME
    Mol Endocrinol; 2005 Oct; 19(10):2491-501. PubMed ID: 15941852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
    Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
    Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
    Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender matters: estrogen receptor alpha (ERĪ±) and histone deacetylase (HDAC) 1 and 2 control the gender-specific transcriptional regulation of human uridine diphosphate glucuronosyltransferases genes (UGT1A).
    Kalthoff S; Winkler A; Freiberg N; Manns MP; Strassburg CP
    J Hepatol; 2013 Oct; 59(4):797-804. PubMed ID: 23714156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
    Hall JM; McDonnell DP
    Endocrinology; 1999 Dec; 140(12):5566-78. PubMed ID: 10579320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells.
    Monroe DG; Secreto FJ; Subramaniam M; Getz BJ; Khosla S; Spelsberg TC
    Mol Endocrinol; 2005 Jun; 19(6):1555-68. PubMed ID: 15802376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.
    Jiang S; Meyer R; Kang K; Osborne CK; Wong J; Oesterreich S
    Mol Endocrinol; 2006 Feb; 20(2):311-20. PubMed ID: 16195251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular determinants for the tissue specificity of SERMs.
    Shang Y; Brown M
    Science; 2002 Mar; 295(5564):2465-8. PubMed ID: 11923541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
    Kim K; Thu N; Saville B; Safe S
    Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
    Zhou S; Turgeman G; Harris SE; Leitman DC; Komm BS; Bodine PV; Gazit D
    Mol Endocrinol; 2003 Jan; 17(1):56-66. PubMed ID: 12511606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coactivators PGC-1beta and SRC-1 interact functionally to promote the agonist activity of the selective estrogen receptor modulator tamoxifen.
    Kressler D; Hock MB; Kralli A
    J Biol Chem; 2007 Sep; 282(37):26897-26907. PubMed ID: 17631495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes.
    Yamamoto Y; Wada O; Suzawa M; Yogiashi Y; Yano T; Kato S; Yanagisawa J
    J Biol Chem; 2001 Nov; 276(46):42684-91. PubMed ID: 11553641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen receptor-alpha with the 3',5'-cyclic adenosine monophosphate response element-binding protein-binding protein/p300 coactivators.
    Jaber BM; Gao T; Huang L; Karmakar S; Smith CL
    Mol Endocrinol; 2006 Nov; 20(11):2695-710. PubMed ID: 16840538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
    Liu Z; Shi HY; Nawaz Z; Zhang M
    Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1.
    Wittmann BM; Fujinaga K; Deng H; Ogba N; Montano MM
    Oncogene; 2005 Aug; 24(36):5576-88. PubMed ID: 15940264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.
    Levy N; Zhao X; Tang H; Jaffe RB; Speed TP; Leitman DC
    Endocrinology; 2007 Jul; 148(7):3449-58. PubMed ID: 17395694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo.
    Liu XF; Bagchi MK
    J Biol Chem; 2004 Apr; 279(15):15050-8. PubMed ID: 14722073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.